Clinical Oncology
Volume 20, Issue 10 , Pages 757-762 , December 2008

Helicobacter pylori Infection and Oesophageal Cancer Risk: Association Studies via Evidence-based Meta-analyses

  • Xianlu Zhuo

      Affiliations

    • Department of Otolaryngology, Southwest Hospital, Third Military Medical University, Chongqing, China
    • ,
  • Yao Zhang

      Affiliations

    • Department of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China
    • ,
  • Yan Wang

      Affiliations

    • Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, China
    • ,
  • Wenlei Zhuo

      Affiliations

    • Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China
    • Corresponding Author InformationAuthor for correspondence: Wenlei Zhuo, Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037 China. Tel/Fax: +86-23-68754405.
    • ,
  • Yi Zhu

      Affiliations

    • College of Food Science and Nutritional Engineering, China Agriculture University, Beijing, China
    • ,
  • Xueyuan Zhang

      Affiliations

    • Department of Otolaryngology, Southwest Hospital, Third Military Medical University, Chongqing, China
    • Corresponding Author InformationAuthor for correspondence: Xueyuan Zhang, Department of Otolaryngology, Southwest Hospital,Third Military Medical University, Chongqing, 400038 China. Tel/Fax: +86-23-68754405.

Received 21 December 2007 ,Revised 21 July 2008 ,Accepted 29 July 2008.

References 

  1. Khanzode SS, Khanzode SD, Dakhale GN. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett. 2003;195:27–31
  2. Arkkila PE, Kokkola A, Seppala K, et al. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics. Scand J Gastroenterol. 2007;42:695–701
  3. Li XB, Ge ZZ, Chen XY, et al. Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis. Braz J Med Biol Res. 2007;40:897–902
  4. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol. 2007;102:1789–1798
  5. Bourke B. Will treatment of Helicobacter pylori infection in childhood alter the risk of developing gastric cancer?. Can J Gastroenterol. 2005;19:409–411
  6. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans . Helicobacter pylori Schistosomes, liver flukes and Helicobacter pylori: views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC; 1994;177–240
  7. Treiber G, Wittig J, Ammon S, et al. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Med. 2002;162:153–160
  8. Roche N, Ilver D, Angstrom J, et al. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. Microbes Infect. 2007;9:605–614
  9. Igarashi M, Kitada Y, Yoshiyama H, et al. Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection. Infect Immun. 2001;69:816–821
  10. Kitadai Y, Sasaki A, Ito M, et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun. 2003;311:809–814
  11. Yokoyama A, Yokoyama T, Omori T, et al. Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men. J Gastroenterol Hepatol. 2007;22:210–217
  12. Kamangar F, Qiao YL, Schiller JT, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer. 2006;119:579–584
  13. Rosenthal R. The ‘file drawer problem’ and tolerance for null results. Psychol Bull. 1979;86:638–641
  14. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–634
  15. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588–590
  16. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50–57
  17. Grimley CE, Holder RL, Loft DE, et al. Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol. 1999;11:503–509
  18. Vieth M, Masoud B, Meining A, et al. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia?. Digestion. 2000;62:225–231
  19. Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol. 2000;95:387–394
  20. Wu AH, Crabtree JE, Bernstein L, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer. 2003;103:815–821
  21. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis. 2005;191:761–767
  22. Henrik Simán J, Forsgren A, Berglund G, et al. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter. 2001;6:310–316
  23. Wu DC, Wu IC, Lee JM, et al. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol. 2005;100:588–593
  24. Kamangar F, Qiao YL, Blaser MJ, et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer. 2007;96:172–176
  25. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193–1201
  26. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388–396
  27. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557–560
  28. Koike T, Ohara S, Inomata Y, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan. Inflammopharmacology. 2007;15:61–64
  29. Shahabi S, Rasmi Y, Jazani NH, et al. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol. 2008;86:175–178

1 Xianlu Zhuo, Yao Zhang, Yan Wang, Wenlei Zhuo and Yi Zhu contributed equally to this study.

PII: S0936-6555(08)00321-X

doi: 10.1016/j.clon.2008.07.005

Clinical Oncology
Volume 20, Issue 10 , Pages 757-762 , December 2008

Article Tools

* Image Usage & Resolution